Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1994; Volume 45,Issue 1
  • You have access
    Differential pharmacology of cloned human and mouse B2 bradykinin receptors.
    J F Hess, J A Borkowski, T Macneil, G Y Stonesifer, J Fraher, C D Strader and R W Ransom
    Molecular Pharmacology January 1994, 45 (1) 1-8;
  • You have access
    Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
    D Aharony, J Little, C Thomas, S Powell, D Berry and A Graham
    Molecular Pharmacology January 1994, 45 (1) 9-19;
  • You have access
    The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
    D R Cerutis, N A Hass, L J Iversen and D B Bylund
    Molecular Pharmacology January 1994, 45 (1) 20-28;
  • You have access
    Neurites induced by staurosporine in PC12 cells are resistant to colchicine and express high levels of tau proteins.
    D Rasouly, E Rahamim, I Ringel, I Ginzburg, C Muarakata, Y Matsuda and P Lazarovici
    Molecular Pharmacology January 1994, 45 (1) 29-35;
  • You have access
    Heat shock response and cytotoxicity in C6 rat glioma cells: structure-activity relationship of different alcohols.
    U Neuhaus-Steinmetz, C Xu, F Fracella, B Oberheitmann, C Richter-Landsberg and L Rensing
    Molecular Pharmacology January 1994, 45 (1) 36-41;
  • You have access
    A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    M Pritchard, S Fournel-Gigleux, G Siest, P Mackenzie and J Magdalou
    Molecular Pharmacology January 1994, 45 (1) 42-50;
  • You have access
    Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.
    C L Chio, M E Lajiness and R M Huff
    Molecular Pharmacology January 1994, 45 (1) 51-60;
  • You have access
    Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors.
    Z Pittel and J Wess
    Molecular Pharmacology January 1994, 45 (1) 61-64;
  • You have access
    Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
    R G Posner, S P Fay, M D Domalewski and L A Sklar
    Molecular Pharmacology January 1994, 45 (1) 65-73;
  • You have access
    Conformers of acetylcholinesterase: a mechanism of allosteric control.
    J L Taylor, R T Mayer and C M Himel
    Molecular Pharmacology January 1994, 45 (1) 74-83;
  • You have access
    Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists.
    D W Sah and B P Bean
    Molecular Pharmacology January 1994, 45 (1) 84-92;
  • You have access
    Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
    A Fournier, D Gagnon, R Quirion, A Cadieux, Y Dumont, L H Pheng and S St-Pierre
    Molecular Pharmacology January 1994, 45 (1) 93-101;
  • You have access
    Ethanol stabilizes the open channel state of the Torpedo nicotinic acetylcholine receptor.
    G Wu, P H Tonner and K W Miller
    Molecular Pharmacology January 1994, 45 (1) 102-108;
  • You have access
    A G protein-activated K+ current in bovine adrenal chromaffin cells: possible regulatory role in exocytosis.
    S D Cannon, S P Wilson and K B Walsh
    Molecular Pharmacology January 1994, 45 (1) 109-116;
  • You have access
    Hydrophobic interactions of n-alkyl diamines with the N-methyl-D-aspartate receptor: voltage-dependent and -independent blocking sites.
    S Subramaniam, S D Donevan and M A Rogawski
    Molecular Pharmacology January 1994, 45 (1) 117-124;
  • You have access
    Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Z B Pristupa, J M Wilson, B J Hoffman, S J Kish and H B Niznik
    Molecular Pharmacology January 1994, 45 (1) 125-135;
  • You have access
    Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
    B E Scanley, R M Baldwin, M Laruelle, M S al-Tikriti, Y Zea-Ponce, S Zoghbi, S S Giddings, D S Charney, P B Hoffer and S Wang
    Molecular Pharmacology January 1994, 45 (1) 136-141;
  • You have access
    Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.
    R L Papke and S F Heinemann
    Molecular Pharmacology January 1994, 45 (1) 142-149;
  • You have access
    Generation of reactive oxygen intermediates by human liver microsomes in the presence of NADPH or NADH.
    J Rashba-Step and A I Cederbaum
    Molecular Pharmacology January 1994, 45 (1) 150-157;
  • You have access
    Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.
    K Veitch and L Hue
    Molecular Pharmacology January 1994, 45 (1) 158-163;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 45, Issue 1
1 Jan 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Cardiac Safety of Doxorubicin
  • Wnt Signaling and Drug Resistance in Cancer
  • Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics